Publications

Publications published since 2010 from OUS - Section for head and neck oncology

239 publications found

Publications 2025

1. Bjelic-Radisic V, Cardoso F, Weis J, Pogoda K, Arraras JI, Greimel E, Bottomley A, Cameron D, Brain E, Hartup S, da Costa Vieira RA, Hoefnagels N, Huang CC, Shamieh O, Pinto M, Belay YB, Serpentini S, Bleiker E, Nookala Krishnamurthy M, Shimomura A, Sturm-Inwald EC, Getu MA, Bliem B, Astrup G, Morag O et al. (2025)
   An international Phase IV field study - psychometric properties of the updated module on assessing quality of life of patients with breast cancer EORTC QLQ-BR42
   Breast, 80, 103890
   DOI 10.1016/j.breast.2025.103890, PubMed 39947087
2. Eriksen JG, Maare C, Johansen J, Primdahl H, Bratland Å, Kristensen CA, Andersen M, Alsner J, Overgaard J, DAHANCA (2025)
   DAHANCA19: A randomized phase III study of primary curative (chemo)-radiotherapy and the EGFR-inhibitor zalutumumab for squamous cell carcinoma of the head and neck
   Radiother Oncol, 208, 110899
   DOI 10.1016/j.radonc.2025.110899, PubMed 40258418
3. Fager A, Samuelsson M, Olofsson Bagge R, Pivodic A, Bjursten S, Levin M, Jespersen H, Ny L (2025)
   Immune checkpoint inhibitor therapy is associated with a decreased risk of developing melanoma brain metastases
   BJC Rep, 3 (1), 22
   DOI 10.1038/s44276-025-00137-2, PubMed 40217072
4. Gjelsvik YM, Myklebust TÅ, Fosså SD, Haug ES, Kvåle R, Ursin G, Johannesen TB (2025)
   A nationwide, longitudinal collection of patient-reported outcomes from prostate cancer patients and controls
   Qual Life Res (in press)
   DOI 10.1007/s11136-025-04017-7, PubMed 40603678
5. Harba D, Corell A, Mansouri A, Brandal P, Blomstrand M, Jakola AS (2025)
   A scoping review of proton radiation therapy and mutant-isocitrate dehydrogenase-inhibitors in IDH mutated lower-grade gliomas: pushing beyond surrogate end-points
   Acta Neurochir (Wien), 167 (1), 196
   DOI 10.1007/s00701-025-06612-6, PubMed 40682696
6. Heggebø LC, Borgen IMH, Blakstad H, Saxhaug C, Rønning PA, Niehusmann PF, Werlenius K, Blomstrand M, Brandal P (2025)
   Case report: Pseudoprogression mimicking neoplastic recurrence three months after completion of proton beam therapy for an IDH-mutant astrocytoma CNS WHO grade 3
   Front Oncol, 15, 1397912
   DOI 10.3389/fonc.2025.1397912, PubMed 39949738
7. Heggebø LC, Garrote FLB, Fjæra LF, Hervani M, Ramberg C, Ottestad A, Blakstad H, Martens T, Rueegg CS, Gustavsson M, Henry T, Blomstrand M, Hellebust TP, Brandal P (2025)
   Protons or Photons in Pituitary Neuroendocrine Tumors-That Is Not the Question
   Int J Part Ther, 17, 101194
   DOI 10.1016/j.ijpt.2025.101194, PubMed 40678408
8. Karlsson AT, Hjermstad MJ, Aass N, Skovlund E, Astrup GL, Kaasa S, Yri OE (2025)
   Patient-Reported Outcomes Before and After Radiotherapy for Brain Metastases-A Prospective Cohort Study of 239 Non-Small-Cell Lung Cancer Patients
   Cancers (Basel), 17 (9)
   DOI 10.3390/cancers17091529, PubMed 40361454
9. Kvestad E, Aarhus L (2025)
   [Not Available]
   Tidsskr Nor Laegeforen, 145 (7)
   DOI 10.4045/tidsskr.25.0266, PubMed 40474627
10. Liu Q, Fuster-Garcia E, Thokle Hovden I, MacIntosh BJ, Grodem EOS, Brandal P, Lopez-Mateu C, Sederevicius D, Skogen K, Schellhorn T, Bjornerud A, Eeg Emblem K (2025)
    Treatment-Aware Diffusion Probabilistic Model for Longitudinal MRI Generation and Diffuse Glioma Growth Prediction
    IEEE Trans Med Imaging, 44 (6), 2449-2462
    DOI 10.1109/TMI.2025.3533038, PubMed 40031286
11. Mair MJ, Lohmann P, Galldiks N, Belting M, Brandal P, Broen MPG, Cicone F, Daisne JF, Ducray F, Ehret F, Furtner J, Jakola AS, Niyazi M, Pellerino A, Rasschaert M, Razis E, Sahm F, Smits M, Tolboom N, Verger A, Le Rhun E, Minniti G, Weller M, Preusser M, Albert NL (2025)
    Availability and use of PET in patients with brain tumours - a European Organisation for Research and Treatment of Cancer - Brain Tumour Group (EORTC-BTG) survey
    Eur J Nucl Med Mol Imaging (in press)
    DOI 10.1007/s00259-025-07366-0, PubMed 40464806
12. Storaas E, Switlyk MD, Dahl S, Amdal CD, Bratland Å, Huynh TM, Eide HA, Vischioni B, Orlandi E, Dale E (2025)
    Distinct patterns of osteoradionecrosis after photon-based radiotherapy and carbon ion radiotherapy for unresectable adenoid cystic carcinoma of the head and neck: case series from two institutions
    Acta Oncol, 64, 63-68
    DOI 10.2340/1651-226X.2025.42209, PubMed 39813173
13. Tahara M, Greil R, Rischin D, Harrington KJ, Burtness B, de Castro G, Psyrri A, Braña I, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesía R, Ngamphaiboon N, Rordorf T, Ishak WZW, Lin J, Gumuscu B, Lerman N, Soulières D (2025)
    Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up from the randomized phase III KEYNOTE-048 study
    Eur J Cancer, 221, 115395
    DOI 10.1016/j.ejca.2025.115395, PubMed 40262400
14. Thomassen D, Roychoudhury S, Amdal CD, Reynders D, Musoro JZ, Sauerbrei W, Goetghebeur E, le Cessie S, SISAQOL-IMI Work Package 3 (2025)
    Handling missing values in patient-reported outcome data in the presence of intercurrent events
    BMC Med Res Methodol, 25 (1), 56
    DOI 10.1186/s12874-025-02510-8, PubMed 40025441

Publications 2024

1. Blakstad H, Mendoza Mireles EE, Kierulf-Vieira KS, Singireddy D, Mdala I, Heggebø LC, Magelssen H, Sprauten M, Johannesen TB, Leske H, Niehusmann P, Skogen K, Helseth E, Emblem KE, Vik-Mo EO, Brandal P (2024)
   The impact of cancer patient pathway on timing of radiotherapy and survival: a cohort study in glioblastoma patients
   J Neurooncol, 169 (1), 137-145
   DOI 10.1007/s11060-024-04709-z, PubMed 38762830
2. Eide NA, Noer A, Jespersen H, Jebsen P, Geisler J (2024)
   Delayed Distant Recurrence of a Uveal Melanoma 4 Decades after Enucleation
   Case Rep Oncol, 17 (1), 1131-1139
   DOI 10.1159/000541341, PubMed 39474560
3. Fange Gjelstad IM, Lyckander C, Høidalen A, Bratland Å, Blomhoff R, Paur I, Henriksen C (2024)
   Impact of radiotherapy on body weight in head and neck cancer patients: A prospective study
   Clin Nutr ESPEN, 65, 390-399
   DOI 10.1016/j.clnesp.2024.12.019, PubMed 39710169
4. Felip E, Metro G, Soo RA, Wolf J, Solomon BJ, Tan DS, Ardizzoni A, Lee DH, Sequist LV, Barlesi F, Ponce-Aix S, Abreu DR, Campelo MRG, Sprauten M, Djentuh LO, Smith N, Jary A, Belli R, Glaser S, Zou M, Cui X, Giovannini M, Yang JC (2024)
   Capmatinib plus nazartinib in patients with EGFR-mutated non-small cell lung cancer
   Eur J Cancer, 208, 114182
   DOI 10.1016/j.ejca.2024.114182, PubMed 38986421
5. Frich L, Hermann R, Ryder T (2024)
   Breast implant-associated anaplastic large cell lymphoma
   Tidsskr Nor Laegeforen, 144 (12)
   DOI 10.4045/tidsskr.24.0315, PubMed 39404238
6. Halldorsson S, Nagymihaly RM, Patel A, Brandal P, Panagopoulos I, Leske H, Lund-Iversen M, Sahm F, Vik-Mo EO (2024)
   Accurate and comprehensive evaluation of O6-methylguanine-DNA methyltransferase promoter methylation by nanopore sequencing
   Neuropathol Appl Neurobiol, 50 (3), e12984
   DOI 10.1111/nan.12984, PubMed 38783575
7. Heggebø LC, Blakstad H, Eriksson MC, Brandal P (2024)
   Lomustine overdose in a patient with diffuse glioma: symptoms, management and outcome
   BMJ Case Rep, 17 (7)
   DOI 10.1136/bcr-2024-260450, PubMed 39043464
8. Huynh BN, Groendahl AR, Tomic O, Liland KH, Knudtsen IS, Hoebers F, van Elmpt W, Dale E, Malinen E, Futsaether CM (2024)
   Deep learning with uncertainty estimation for automatic tumor segmentation in PET/CT of head and neck cancers: impact of model complexity, image processing and augmentation
   Biomed Phys Eng Express, 10 (5)
   DOI 10.1088/2057-1976/ad6dcd, PubMed 39127060
9. Huynh BN, Groendahl AR, Tomic O, Liland KH, Knudtsen IS, Hoebers F, van Elmpt W, Malinen E, Dale E, Futsaether CM (2024)
   Corrigendum: Head and neck cancer treatment outcome prediction: a comparison between machine learning with conventional radiomics features and deep learning radiomics
   Front Med (Lausanne), 11, 1421603
   DOI 10.3389/fmed.2024.1421603, PubMed 38813378
10. Huynh TM, Falk RS, Hellebust TP, Dale E, Astrup GL, Hjermstad MJ, Malinen E, Bjordal K, Kiserud CE, Herlofson BB, Nome R, Amdal CD (2024)
    Chronic fatigue in long-term survivors of head and neck cancer treated with radiotherapy
    Radiother Oncol, 195, 110231
    DOI 10.1016/j.radonc.2024.110231, PubMed 38518958
11. Ilmarinen T, Bratland Å, Tøndel H, Guðjónsson A, Gebre-Medhin M, Palmgren B, Mäenpää H, Bjørndal K, Grau Eriksen J (2024)
    Current aspects of the quality of head and neck cancer care - survey of the Scandinavian Society for Head and Neck Oncology
    Acta Otolaryngol, 144 (5-6), 404-408
    DOI 10.1080/00016489.2024.2386097, PubMed 39109489
12. Kristensen MH, Holm AIS, Hansen CR, Zukauskaite R, Samsøe E, Maare C, Johansen J, Primdahl H, Bratland Å, Kristensen CA, Andersen M, Overgaard J, Eriksen JG (2024)
    High-dose loco-regional pattern of failure after primary radiotherapy in p16 positive and negative head and neck squamous cell carcinoma - A DAHANCA 19 study
    Clin Transl Radiat Oncol, 46, 100772
    DOI 10.1016/j.ctro.2024.100772, PubMed 38596816
13. Kristensen MH, Sørensen MK, Tramm T, Alsner J, Sørensen BS, Maare C, Johansen J, Primdahl H, Bratland Å, Kristensen CA, Andersen M, Lilja-Fischer JK, Holm AIS, Samsøe E, Hansen CR, Zukauskaite R, Overgaard J, Eriksen JG (2024)
    Tumor volume and cancer stem cell expression as prognostic markers for high-dose loco-regional failure in head and neck squamous cell carcinoma - A DAHANCA 19 study
    Radiother Oncol, 193, 110149
    DOI 10.1016/j.radonc.2024.110149, PubMed 38341096
14. Nymoen HM, Alver TN, Horndalsveen H, Eide HA, Bjaanæs MM, Brustugun OT, Grønberg BH, Haakensen VD, Helland Å (2024)
    Thoracic radiation in combination with erlotinib-results from a phase 2 randomized trial
    Front Oncol, 14, 1412716
    DOI 10.3389/fonc.2024.1412716, PubMed 39148905
15. Prysiazhniuk Y, Server A, Leske H, Bech-Aase Ø, Helseth E, Eijgelaar RS, Fuster-García E, Brandal P, Bjørnerud A, Otáhal J, Petr J, Nordhøy W (2024)
    Diffuse glioma molecular profiling with arterial spin labeling and dynamic susceptibility contrast perfusion MRI: A comparative study
    Neurooncol Adv, 6 (1), vdae113
    DOI 10.1093/noajnl/vdae113, PubMed 39036439
16. Reis Costa D, Winge-Main AK, Skog A, Tsuruda KM, Robsahm TE, Kulle Andreassen B (2024)
    From trials to practice: Immune checkpoint inhibitor therapy for melanoma patients in Norway
    Acta Oncol, 63, 965-973
    DOI 10.2340/1651-226X.2024.41266, PubMed 39690735
17. Singer S, Hammerlid E, Tomaszewska IM, Amdal CD, Herlofson BB, Santos M, Castro Silva J, Mehanna H, Fullerton A, Young T, Fernandez Gonzalez L, Inhestern J, Pinto M, Arraras JI, Yarom N, Bonomo P, Baumann I, Galalae R, Nicolatou-Galitis O, Kiyota N, Raber-Durlacher J, Salem D, Fabian A, Boehm A, Krejovic-Trivic S et al. (2024)
    The european organisation for research and treatment of cancer head and neck cancer module (EORTC QLQ-HN43): Estimates for minimal important difference and minimal important change
    Eur J Cancer, 212, 115062
    DOI 10.1016/j.ejca.2024.115062, PubMed 39405647
18. Tabouret E, Furtner J, Graillon T, Silvani A, Le Rhun E, Soffietti R, Lombardi G, Sepúlveda-Sánchez JM, Brandal P, Bendszus M, Golfinopoulos V, Gorlia T, Weller M, Sahm F, Wick W, Preusser M (2024)
    3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas
    Neuro Oncol, 26 (7), 1302-1309
    DOI 10.1093/neuonc/noae037, PubMed 38452246
19. Tauziède-Espariat A, Nicaise Y, Sievers P, Sahm F, von Deimling A, Guillemot D, Pierron G, Duchesne M, Edjlali M, Dangouloff-Ros V, Boddaert N, Roux A, Dezamis E, Hasty L, Lhermitte B, Hirsch E, Hirsch MPV, Ardellier FD, Karnoub MA, Csanyi M, Maurage CA, Mokhtari K, Bielle F, Rigau V, Roujeau T et al. (2024)
    CNS tumors with PLAGL1-fusion: beyond ZFTA and YAP1 in the genetic spectrum of supratentorial ependymomas
    Acta Neuropathol Commun, 12 (1), 55
    DOI 10.1186/s40478-023-01695-7, PubMed 38581034
20. Taylor KJ, Amdal CD, Bjordal K, Astrup GL, Herlofson BB, Duprez F, Gama RR, Jacinto A, Hammerlid E, Scricciolo M, Jansen F, Verdonck-de Leeuw IM, Fanetti G, Guntinas-Lichius O, Inhestern J, Dragan T, Fabian A, Boehm A, Wöhner U, Kiyota N, Krüger M, Bonomo P, Pinto M, Nuyts S, Silva JC et al. (2024)
    Long-term health-related quality of life in head and neck cancer survivors: A large multinational study
    Int J Cancer, 154 (10), 1772-1785
    DOI 10.1002/ijc.34861, PubMed 38312044
21. Thomassen D, Roychoudhury S, Amdal CD, Reynders D, Musoro JZ, Sauerbrei W, Goetghebeur E, le Cessie S, SISAQOL-IMI Work Package 3 (2024)
    The role of the estimand framework in the analysis of patient-reported outcomes in single-arm trials: a case study in oncology
    BMC Med Res Methodol, 24 (1), 290
    DOI 10.1186/s12874-024-02408-x, PubMed 39580440
22. Yri OE, Astrup GL, Karlsson AT, van Helvoirt R, Hjermstad MJ, Husby KM, Loge JH, Lund JÅ, Lundeby T, Paulsen Ø, Skovlund E, Taran MI, Winther RR, Aass N, Kaasa S (2024)
    Survival and quality of life after first-time diagnosis of brain metastases: a multicenter, prospective, observational study
    Lancet Reg Health Eur, 49, 101181
    DOI 10.1016/j.lanepe.2024.101181, PubMed 39807153

Publications 2023

1. Amdal CD, Moan JM, Dale E, Falk RS, Johansen S, Bjordal K (2023)
   Impact of hyperfractionated re-irradiation on quality of life in patients with recurrent or second primary head and neck cancer, a prospective single institutional study
   Clin Transl Radiat Oncol, 42, 100654
   DOI 10.1016/j.ctro.2023.100654, PubMed 37415638
2. Bartula I, Tran AD, Nowak AK, Ahmed T, Morton RL, Burmeister BH, Dolven-Jacobsen K, Nobes J, Thompson JF, Fogarty GB, Lo SN, Hong AM (2023)
   Longitudinal trajectory of quality of life for patients with melanoma brain metastases: A secondary analysis from a whole brain radiotherapy randomized clinical trial
   Clin Transl Radiat Oncol, 41, 100597
   DOI 10.1016/j.ctro.2023.100597, PubMed 37441544
3. Blakstad H, Brekke J, Rahman MA, Arnesen VS, Miletic H, Brandal P, Lie SA, Chekenya M, Goplen D (2023)
   Survival in a consecutive series of 467 glioblastoma patients: Association with prognostic factors and treatment at recurrence at two independent institutions
   PLoS One, 18 (2), e0281166
   DOI 10.1371/journal.pone.0281166, PubMed 36730349
4. Blakstad H, Mendoza Mireles EE, Heggebø LC, Magelssen H, Sprauten M, Johannesen TB, Vik-Mo EO, Leske H, Niehusmann P, Skogen K, Helseth E, Emblem KE, Brandal P (2023)
   Incidence and outcome of pseudoprogression after radiation therapy in glioblastoma patients: A cohort study
   Neurooncol Pract, 11 (1), 36-45
   DOI 10.1093/nop/npad063, PubMed 38222046
5. Bratland Å, Munoz-Couselo E, Mortier L, Roshdy O, González R, Schachter J, Arance AM, Grange F, Meyer N, Joshi AJ, Billan S, Hughes BGM, Grob JJ, Ramakrishnan K, Ge J, Gumuscu B, Swaby RF, Gutzmer R (2023)
   Health-Related Quality of Life with Pembrolizumab in Patients with Locally Advanced or Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: KEYNOTE-629
   Dermatol Ther (Heidelb), 13 (12), 3165-3180
   DOI 10.1007/s13555-023-01059-y, PubMed 37943491
6. Garset-Zamani M, von Buchwald C, Karevold G, Agander TK, Mateu-Regué À, Eide HA, Tvedskov JF (2023)
   An HPV-Vaccinated Patient With Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma
   JAMA Otolaryngol Head Neck Surg, 149 (1), 92-94
   DOI 10.1001/jamaoto.2022.3762, PubMed 36416857
7. Groendahl AR, Huynh BN, Tomic O, Søvik Å, Dale E, Malinen E, Skogmo HK, Futsaether CM (2023)
   Automatic gross tumor segmentation of canine head and neck cancer using deep learning and cross-species transfer learning
   Front Vet Sci, 10, 1143986
   DOI 10.3389/fvets.2023.1143986, PubMed 37026102
8. Harrington KJ, Ferris RL, Gillison M, Tahara M, Argiris A, Fayette J, Schenker M, Bratland Å, Walker JWT, Grell P, Even C, Chung CH, Redman R, Coutte A, Salas S, Grant C, de Azevedo S, Soulières D, Hansen AR, Wei L, Khan TA, Miller-Moslin K, Roberts M, Haddad R (2023)
   Efficacy and Safety of Nivolumab Plus Ipilimumab vs Nivolumab Alone for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: The Phase 2 CheckMate 714 Randomized Clinical Trial
   JAMA Oncol, 9 (6), 779-789
   DOI 10.1001/jamaoncol.2023.0147, PubMed 37022706
9. Heggebø LC, Borgen IMH, Rylander H, Kiserud C, Nordenmark TH, Hellebust TP, Evensen ME, Gustavsson M, Ramberg C, Sprauten M, Magelssen H, Blakstad H, Moorthy J, Andersson K, Raunert I, Henry T, Moe C, Granlund C, Goplen D, Brekke J, Johannessen TA, Solheim TS, Marienhagen K, Humberset Ø, Bergström P et al. (2023)
   Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH-mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden
   BMJ Open, 13 (3), e070071
   DOI 10.1136/bmjopen-2022-070071, PubMed 36940951
10. Huynh BN, Groendahl AR, Tomic O, Liland KH, Knudtsen IS, Hoebers F, van Elmpt W, Malinen E, Dale E, Futsaether CM (2023)
    Head and neck cancer treatment outcome prediction: a comparison between machine learning with conventional radiomics features and deep learning radiomics
    Front Med (Lausanne), 10, 1217037
    DOI 10.3389/fmed.2023.1217037, PubMed 37711738
11. Huynh TM, Dale E, Falk RS, Hellebust TP, Astrup GL, Malinen E, Edin NFJ, Bjordal K, Herlofson BB, Kiserud CE, Helland Å, Amdal CD (2023)
    Radiation-induced long-term dysphagia in survivors of head and neck cancer and association with dose-volume parameters
    Radiother Oncol, 190, 110044
    DOI 10.1016/j.radonc.2023.110044, PubMed 38061420
12. Leske H, Blakstad H, Lund-Iversen M, Skovholt EK, Niehusmann P, Ramm-Pettersen JT, Skogen K, Kongelf G, Sprauten M, Magelssen H, Brandal P (2023)
    Astrocytoma (CNS WHO grade 4), IDH-mutant with co-occurrence of BRAF p.V600E mutation, and homozygous loss of CDKN2A
    Neuropathology, 43 (5), 385-390
    DOI 10.1111/neup.12895, PubMed 36754566
13. Liu L, Choi J, Musoro JZ, Sauerbrei W, Amdal CD, Alanya A, Barbachano Y, Cappelleri JC, Falk RS, Fiero MH, Regnault A, Reijneveld JC, Sandin R, Thomassen D, Roychoudhury S, Goetghebeur E, le Cessie S, SISAQOL-IMI Work Package 3 (2023)
    Single-arm studies involving patient-reported outcome data in oncology: a literature review on current practice
    Lancet Oncol, 24 (5), e197-e206
    DOI 10.1016/S1470-2045(23)00110-9, PubMed 37142381
14. Mendoza Mireles EE, Skaga E, Server A, Leske H, Brandal P, Helseth E, Rønning PA, Vik-Mo EO (2023)
    The benefit of complete resection of contrast enhancing tumor in glioblastoma patients: A population-based study
    Neurooncol Pract, 10 (6), 555-564
    DOI 10.1093/nop/npad037, PubMed 38026582
15. Ottesen JA, Yi D, Tong E, Iv M, Latysheva A, Saxhaug C, Jacobsen KD, Helland Å, Emblem KE, Rubin DL, Bjørnerud A, Zaharchuk G, Grøvik E (2023)
    2.5D and 3D segmentation of brain metastases with deep learning on multinational MRI data
    Front Neuroinform, 16, 1056068
    DOI 10.3389/fninf.2022.1056068, PubMed 36743439
16. Pe M, Alanya A, Falk RS, Amdal CD, Bjordal K, Chang J, Cislo P, Coens C, Dirven L, Speck RM, Fitzgerald K, Galinsky J, Giesinger JM, Holzner B, Le Cessie S, O'Connor D, Oliver K, Pawar V, Quinten C, Schlichting M, Ren J, Roychoudhury S, Taphoorn MJB, Velikova G, Wintner LM et al. (2023)
    Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures
    Lancet Oncol, 24 (6), e270-e283
    DOI 10.1016/S1470-2045(23)00157-2, PubMed 37269858
17. Richartz N, Pietka W, Yadav A, Bostad M, Bhagwat S, Naderi S, Naderi EH, Stokke T, Ruud E, Blomhoff HK (2023)
    N-acetyl cysteine turns EPAC activators into potent killers of acute lymphoblastic leukemia cells
    J Biol Chem, 300 (1), 105509
    DOI 10.1016/j.jbc.2023.105509, PubMed 38042493
18. Rohde M, Eriksen JG, Pareek M, Bratland Å, Mäkitie A, Hammarstedt-Nordenvall L, Wessel I, Lybeck JS, Mäenpää H, Gebre-Medhin M, Godballe C (2023)
    Diagnosis of locally recurrent head and neck squamous cell carcinoma in the Nordic HNC centers and feasibility of the Odense-Birmingham definition
    Acta Oncol, 62 (9), 1102-1105
    DOI 10.1080/0284186X.2023.2245550, PubMed 37602835
19. Sah VR, Jespersen H, Karlsson J, Nilsson LM, Bergqvist M, Johansson I, Carneiro A, Helgadottir H, Levin M, Ullenhag G, Ståhlberg A, Olofsson Bagge R, Nilsson JA, Ny L (2023)
    Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy
    Cancer Res Commun, 3 (5), 884-895
    DOI 10.1158/2767-9764.CRC-22-0490, PubMed 37377898
20. Schipmann-Miletic S, Sivakanesan S, Rath DS, Brandal P, Vik-Mo E, Bjørås M, Solheim O, Ingebrigtsen T, Sund F, Bjerkvig R, Miletic H, Johannessen TA, Sundstrøm T (2023)
    [Glioblastoma in adults]
    Tidsskr Nor Laegeforen, 143 (2)
    DOI 10.4045/tidsskr.22.0314, PubMed 36718891
21. Taylor KJ, Amdal CD, Bjordal K, Astrup GL, Herlofson BB, Duprez F, Gama RR, Jacinto A, Hammerlid E, Scricciolo M, Jansen F, Verdonck-de Leeuw IM, Fanetti G, Guntinas-Lichius O, Inhestern J, Dragan T, Fabian A, Boehm A, Wöhner U, Kiyota N, Krüger M, Bonomo P, Pinto M, Nuyts S, Silva JC et al. (2023)
    Serious Long-Term Effects of Head and Neck Cancer from the Survivors' Point of View
    Healthcare (Basel), 11 (6)
    DOI 10.3390/healthcare11060906, PubMed 36981562
22. Trøseid M, Arribas JR, Assoumou L, Holten AR, Poissy J, Terzić V, Mazzaferri F, Baño JR, Eustace J, Hites M, Joannidis M, Paiva JA, Reuter J, Püntmann I, Patrick-Brown TDJH, Westerheim E, Nezvalova-Henriksen K, Beniguel L, Dahl TB, Bouscambert M, Halanova M, Péterfi Z, Tsiodras S, Rezek M, Briel M et al. (2023)
    Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial
    Crit Care, 27 (1), 9
    DOI 10.1186/s13054-022-04205-8, PubMed 36627655
23. Winge-Main A, Robsahm TE, Nyakas M, Festervoll G, Torkilseng E, Thybo S, Pati S, Carroll R (2023)
    Long-term outcomes of stage IIB-IV melanoma patients: nationwide data from Norway
    Future Oncol, 19 (3), 205-215
    DOI 10.2217/fon-2022-0969, PubMed 36974621
24. Yi D, Grøvik E, Tong E, Iv M, Emblem KE, Nilsen LB, Saxhaug C, Latysheva A, Jacobsen KD, Helland Å, Zaharchuk G, Rubin D (2023)
    Erratum: "MRI pulse sequence integration for deep-learning-based brain metastases segmentation"
    Med Phys, 50 (8), 5294
    DOI 10.1002/mp.16594, PubMed 37573581

Publications 2022

1. Amdal CD, Falk RS, Singer S, Pe M, Piccinin C, Bottomley A, Appiah LT, Arraras JI, Bayer O, Buanes EA, Darlington AS, Arbanas GD, Hofsø K, Holzner B, Sahlstrand-Johnson P, Kuliś D, Parmar G, Rmeileh NMEA, Schranz M, Sodergren S, Bjordal K (2022)
   A multicenter international prospective study of the validity and reliability of a COVID-19-specific health-related quality of life questionnaire
   Qual Life Res, 32 (2), 447-459
   DOI 10.1007/s11136-022-03272-2, PubMed 36273365
2. Amdal CD, Taylor K, Kuliś D, Falk RS, Bottomley A, Arraras JI, Barte JH, Darlington AS, Hofsø K, Holzner B, Jørgensen NMH, Mariano MP, Pe M, Piccinin C, Riccetti N, Schranz M, Wheelwright S, Bjordal K (2022)
   Health-related quality of life in patients with COVID-19; international development of a patient-reported outcome measure
   J Patient Rep Outcomes, 6 (1), 26
   DOI 10.1186/s41687-022-00434-1, PubMed 35348945
3. Berentzen Å, Brevig T, Hermann R, Ryder T, Winge-Main AK (2022)
   Melanoma - investigation and primary treatment
   Tidsskr Nor Laegeforen, 142 (15)
   DOI 10.4045/tidsskr.22.0043, PubMed 36286571
4. Berentzen Å, Brevig T, Hermann R, Ryder T, Winge-Main AK (2022)
   Correction: Melanoma - investigation and primary treatment
   Tidsskr Nor Laegeforen, 142 (1)
   DOI 10.4045/tidsskr.22.0806, PubMed 36655962
5. Blakstad H, Wohlleben C, Saxhaug C, Brandal P (2022)
   SMART syndrome: two cases highlighting a complex and rare complication of brain irradiation
   BMJ Case Rep, 15 (9)
   DOI 10.1136/bcr-2022-249599, PubMed 36167430
6. Burtness B, Rischin D, Greil R, Soulières D, Tahara M, de Castro G, Psyrri A, Brana I, Basté N, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesia R, Ngamphaiboon N, Rordorf T, Wan Ishak WZ, Ge J, Swaby RF, Gumuscu B, Harrington K (2022)
   Pembrolizumab Alone or With Chemotherapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in KEYNOTE-048: Subgroup Analysis by Programmed Death Ligand-1 Combined Positive Score
   J Clin Oncol, 40 (21), 2321-2332
   DOI 10.1200/JCO.21.02198, PubMed 35333599
7. Evensen ME, Furre T, Malinen E, Løndalen AM, Dale E (2022)
   Mucosa-sparing dose painting of head and neck cancer
   Acta Oncol, 61 (2), 141-145
   DOI 10.1080/0284186X.2021.2022200, PubMed 34991431
8. Harrington KJ, Burtness B, Greil R, Soulières D, Tahara M, de Castro G, Psyrri A, Brana I, Basté N, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesia R, Ngamphaiboon N, Rordorf T, Wan Ishak WZ, Lin J, Gumuscu B, Swaby RF, Rischin D (2022)
   Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study
   J Clin Oncol, 41 (4), 790-802
   DOI 10.1200/JCO.21.02508, PubMed 36219809
9. Hauger SL, Borgen IMH, Løvstad M, Lu J, Forslund MV, Kleffelgård I, Andelic N, Røe C (2022)
   Community-Based Interventions After Acquired Brain Injury-A Systematic Review of Intervention Types and Their Effectiveness
   J Head Trauma Rehabil, 37 (5), E355-E369
   DOI 10.1097/HTR.0000000000000765, PubMed 35125426
10. Husum YS, Skogen K, Brandal P, Rønning PA, Wigers AR, Evang JA, Jørstad ØK (2022)
    Idiopathic Duro-Optic Calcification
    J Neuroophthalmol, 44 (1), e204
    DOI 10.1097/WNO.0000000000001722, PubMed 36255093
11. Huynh TTM, Aass HCD, Falk RS, Astrup GL, Helland Å, Bjøro T, Bjordal K, Dale E, Hellebust TP, Herlofson BB, Malinen E, Kiserud CE, Osnes T, Amdal CD (2022)
    Associations between patient-reported late effects and systemic cytokines in long-term survivors of head and neck cancer treated with radiotherapy
    J Cancer Surviv, 17 (4), 1082-1093
    DOI 10.1007/s11764-022-01273-1, PubMed 36350483
12. Hynne H, Aqrawi LA, Jensen JL, Thiede B, Palm Ø, Amdal CD, Westgaard KL, Herlofson BB, Utheim TP, Galtung HK (2022)
    Proteomic Profiling of Saliva and Tears in Radiated Head and Neck Cancer Patients as Compared to Primary Sjögren's Syndrome Patients
    Int J Mol Sci, 23 (7)
    DOI 10.3390/ijms23073714, PubMed 35409074
13. Ivanova A, Rodríguez-Cano R, Kvalem IL, Harcourt D, Kiserud CE, Amdal CD (2022)
    Body image concerns in long-term head and neck cancer survivors: prevalence and role of clinical factors and patient-reported late effects
    J Cancer Surviv, 17 (2), 526-534
    DOI 10.1007/s11764-022-01311-y, PubMed 36509859
14. Jespersen H (2022)
    Moles and melanoma
    Tidsskr Nor Laegeforen, 142 (15)
    DOI 10.4045/tidsskr.22.0626, PubMed 36286558
15. Kvammen JA, Stensvold E, Godang K, Bollerslev J, Myklebust TÅ, Brandal P, Henriksen C, Bechensteen AG (2022)
    Bone mineral density and nutrition in long-term survivors of childhood brain tumors
    Clin Nutr ESPEN, 50, 162-169
    DOI 10.1016/j.clnesp.2022.05.025, PubMed 35871919
16. Niehusmann P, Stensvold E, Leske H, Pietsch T, Goschzik T, Gielen GH, Due-Tønnessen B, Frič R, Nilssen Y, Brandal P (2022)
    Molecular pathological insights reveal a high number of unfavorable risk patients among children treated for medulloblastoma and CNS-PNET in Oslo 2005-2017
    Pediatr Blood Cancer, 69 (9), e29736
    DOI 10.1002/pbc.29736, PubMed 35570402
17. Nyrud MK, Bratland Å, Landrø L, Brevig T, Ryder T, Hermann R, Frich L (2022)
    Merkel cell carcinoma
    Tidsskr Nor Laegeforen, 142 (9)
    DOI 10.4045/tidsskr.21.0693, PubMed 35699540
18. Preusser M, Silvani A, Le Rhun E, Soffietti R, Lombardi G, Sepulveda JM, Brandal P, Brazil L, Bonneville-Levard A, Lorgis V, Vauleon E, Bromberg J, Erridge S, Cameron A, Lefranc F, Clement PM, Dumont S, Sanson M, Bronnimann C, Balaná C, Thon N, Lewis J, Mair MJ, Sievers P, Furtner J et al. (2022)
    Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG)
    Neuro Oncol, 24 (5), 755-767
    DOI 10.1093/neuonc/noab243, PubMed 34672349
19. Richartz N, Pietka W, Gilljam KM, Skah S, Skålhegg BS, Bhagwat S, Naderi EH, Ruud E, Blomhoff HK (2022)
    cAMP-Mediated Autophagy Promotes Cell Survival via ROS-Induced Activation of PARP1: Implications for Treatment of Acute Lymphoblastic Leukemia
    Mol Cancer Res, 20 (3), 400-411
    DOI 10.1158/1541-7786.MCR-21-0652, PubMed 34880123
20. Rischin D, Harrington KJ, Greil R, Soulières D, Tahara M, de Castro G, Psyrri A, Braña I, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesía R, Ngamphaiboon N, Rordorf T, Ishak WZW, Hong RL, Mendoza RG, Jia L, Chirovsky D, Norquist J, Jin F, Burtness B (2022)
    Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048
    Oral Oncol, 128, 105815
    DOI 10.1016/j.oraloncology.2022.105815, PubMed 35381576
21. Tanem KE, Stensvold E, Wilberg P, Skaare AB, Brandal P, Herlofson BB (2022)
    Oral and dental late effects in long-term survivors of childhood embryonal brain tumors
    Support Care Cancer, 30 (12), 10233-10241
    DOI 10.1007/s00520-022-07405-8, PubMed 36307656
22. Tanem KE, Stensvold E, Wilberg P, Skaare AB, Singh PB, Brandal P, Herlofson BB (2022)
    Taste and smell function in long-term survivors after childhood medulloblastoma/CNS-PNET
    Support Care Cancer, 30 (7), 6155-6162
    DOI 10.1007/s00520-022-07048-9, PubMed 35426047
23. Aamdal E, Skovlund E, Jacobsen KD, Straume O, Kersten C, Herlofsen O, Karlsen J, Hussain I, Amundsen A, Dalhaug A, Nyakas M, Hagene KT, Holmsen K, Aamdal S, Kaasa S, Guren TK, Kyte JA (2022)
    Health-related quality of life in patients with advanced melanoma treated with ipilimumab: prognostic implications and changes during treatment
    ESMO Open, 7 (5), 100588
    DOI 10.1016/j.esmoop.2022.100588, PubMed 36116420

Publications 2021

1. Amdal CD, Pe M, Falk RS, Piccinin C, Bottomley A, Arraras JI, Darlington AS, Hofsø K, Holzner B, Jørgensen NMH, Kulis D, Rimehaug SA, Singer S, Taylor K, Wheelwright S, Bjordal K (2021)
   Health-related quality of life issues, including symptoms, in patients with active COVID-19 or post COVID-19; a systematic literature review
   Qual Life Res, 30 (12), 3367-3381
   DOI 10.1007/s11136-021-02908-z, PubMed 34146226
2. Borgen IMH, Kleffelgård I, Hauger SL, Forslund MV, Søberg HL, Andelic N, Sveen U, Winter L, Løvstad M, Røe C (2021)
   Patient-Reported Problem Areas in Chronic Traumatic Brain Injury
   J Head Trauma Rehabil, 37 (5), E336-E345
   DOI 10.1097/HTR.0000000000000744, PubMed 34743086
3. Chen X, Badian RA, Hynne H, Amdal CD, Herlofson BB, Utheim ØA, Westgaard KL, Fineide F, Jensen JL, Utheim TP (2021)
   Alterations in meibomian glands in patients treated with intensity-modulated radiotherapy for head and neck cancer
   Sci Rep, 11 (1), 22419
   DOI 10.1038/s41598-021-01844-9, PubMed 34789830
4. Groendahl AR, Skjei Knudtsen I, Huynh BN, Mulstad M, Moe YM, Knuth F, Tomic O, Indahl UG, Torheim T, Dale E, Malinen E, Futsaether CM (2021)
   A comparison of methods for fully automatic segmentation of tumors and involved nodes in PET/CT of head and neck cancers
   Phys Med Biol, 66 (6), 065012
   DOI 10.1088/1361-6560/abe553, PubMed 33666176
5. Grøvik E, Yi D, Iv M, Tong E, Nilsen LB, Latysheva A, Saxhaug C, Jacobsen KD, Helland Å, Emblem KE, Rubin DL, Zaharchuk G (2021)
   Handling missing MRI sequences in deep learning segmentation of brain metastases: a multicenter study
   NPJ Digit Med, 4 (1), 33
   DOI 10.1038/s41746-021-00398-4, PubMed 33619361
6. Heck A, Winge-Main AK (2021)
   Silent, isolated ACTH deficiency in malignant melanoma patients treated with immune checkpoint inhibitors
   BMJ Case Rep, 14 (5)
   DOI 10.1136/bcr-2021-241981, PubMed 34045201
7. Husum YS, Skogen K, Brandal P, Rønning PA, Wigers AR, Evang JA, Jørstad ØK (2021)
   Bilateral calcification of the optic nerve sheath: A diagnostic dilemma
   Am J Ophthalmol Case Rep, 22, 101106
   DOI 10.1016/j.ajoc.2021.101106, PubMed 33997471
8. Lundar T, Due-Tønnessen BJ, Frič R, Brandal P, Due-Tønnessen P (2021)
   Choroid Plexus Tumors in Children: Long-Term Follow-Up of Consecutive Single-Institutional Series of 59 Patients Treated over a Period of 8 Decades (1939-2020)
   World Neurosurg, 158, e810-e819
   DOI 10.1016/j.wneu.2021.11.070, PubMed 34823041
9. Lundar T, Due-Tønnessen BJ, Frič R, Sundseth J, Brandal P, Due-Tønnessen P (2021)
   Outcome After Treatment of Spinal Ependymoma in Children and Adolescents: Long-Term Follow-up of a Single Consecutive Institutional Series of 33 Patients Treated Over Eight Decades
   World Neurosurg, 150, e228-e235
   DOI 10.1016/j.wneu.2021.02.131, PubMed 33684583
10. Lundar T, Due-Tønnessen BJ, Frič R, Sundseth J, Brandal P, Due-Tønnessen P (2021)
    Outcome after treatment of pediatric supratentorial ependymoma: long-term follow-up of a single consecutive institutional series of 26 patients
    Br J Neurosurg, 38 (2), 514-522
    DOI 10.1080/02688697.2021.1914821, PubMed 34096810
11. Moe YM, Groendahl AR, Tomic O, Dale E, Malinen E, Futsaether CM (2021)
    Deep learning-based auto-delineation of gross tumour volumes and involved nodes in PET/CT images of head and neck cancer patients
    Eur J Nucl Med Mol Imaging, 48 (9), 2782-2792
    DOI 10.1007/s00259-020-05125-x, PubMed 33559711
12. Singer S, Hammerlid E, Tomaszewska IM, Amdal CD, Bjordal K, Herlofson BB, Santos M, Silva JC, Mehanna H, Fullerton A, Brannan C, Gonzalez LF, Inhestern J, Pinto M, Arraras JI, Yarom N, Bonomo P, Baumann I, Galalae R, Nicolatou-Galitis O, Kiyota N, Raber-Durlacher J, Salem D, Fabian A, Boehm A et al. (2021)
    Methodological approach for determining the Minimal Important Difference and Minimal Important Change scores for the European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module (EORTC QLQ-HN43) exemplified by the Swallowing scale
    Qual Life Res, 31 (3), 841-853
    DOI 10.1007/s11136-021-02939-6, PubMed 34272632
13. Skaga E, Skretteberg MA, Johannesen TB, Brandal P, Vik-Mo EO, Helseth E, Langmoen IA (2021)
    Real-world validity of randomized controlled phase III trials in newly diagnosed glioblastoma: to whom do the results of the trials apply?
    Neurooncol Adv, 3 (1), vdab008
    DOI 10.1093/noajnl/vdab008, PubMed 33665615
14. Switlyk MD, Niehusmann P, Sprauten M, Magelssen H, Aarhus M, Rasmussen FØ, Knutstad K, Brandal P (2021)
    Neurosarcoidosis resembling multiple meningiomas: A misleading presentation of the disease and diagnostic challenge
    Acta Radiol Open, 10 (7), 20584601211036550
    DOI 10.1177/20584601211036550, PubMed 34377543
15. Toussaint L, Brandal P, Embring A, Engellau J, Evensen ME, Griskeviskius R, Hansen J, Hietala H, Wickart Johansson G, Jørgensen M, Kramer PH, Kristensen I, Lehtio K, Magelssen H, Maraldo MV, Marienhagen K, Martinsson U, Nilsson K, Peters S, Plaude S, Seiersen K, Sendiuliene D, Smulders B, Edvardsen T, Søbstad JM et al. (2021)
    Inter-observer variation in target delineation and dose trade-off for radiotherapy of paediatric ependymoma
    Acta Oncol, 61 (2), 235-238
    DOI 10.1080/0284186X.2021.2022202, PubMed 34970940
16. Westgaard KL, Hynne H, Amdal CD, Young A, Singh PB, Chen X, Rykke M, Hove LH, Aqrawi LA, Utheim TP, Herlofson BB, Jensen JL (2021)
    Oral and ocular late effects in head and neck cancer patients treated with radiotherapy
    Sci Rep, 11 (1), 4026
    DOI 10.1038/s41598-021-83635-w, PubMed 33597629
17. Wright P, Arnesen MR, Lønne PI, Suilamo S, Silvoniemi A, Dale E, Minn H, Malinen E (2021)
    Repeatability of hypoxia dose painting by numbers based on EF5-PET in head and neck cancer
    Acta Oncol, 60 (11), 1386-1391
    DOI 10.1080/0284186X.2021.1944663, PubMed 34184605
18. Yi D, Grøvik E, Tong E, Iv M, Emblem KE, Nilsen LB, Saxhaug C, Latysheva A, Jacobsen KD, Helland Å, Zaharchuk G, Rubin D (2021)
    MRI pulse sequence integration for deep-learning-based brain metastases segmentation
    Med Phys, 48 (10), 6020-6035
    DOI 10.1002/mp.15136, PubMed 34405896
19. Aamdal E, Jacobsen KD, Straume O, Kersten C, Herlofsen O, Karlsen J, Hussain I, Amundsen A, Dalhaug A, Nyakas M, Schuster C, Hagene KT, Holmsen K, Russnes HG, Skovlund E, Kaasa S, Aamdal S, Kyte JA, Guren TK (2021)
    Ipilimumab in a real-world population: A prospective Phase IV trial with long-term follow-up
    Int J Cancer, 150 (1), 100-111
    DOI 10.1002/ijc.33768, PubMed 34449877

Publications 2020

1. Abravan A, Eide HA, Helland Å, Malinen E (2020)
   Radiotherapy-related lymphopenia in patients with advanced non-small cell lung cancer receiving palliative radiotherapy
   Clin Transl Radiat Oncol, 22, 15-21
   DOI 10.1016/j.ctro.2020.02.005, PubMed 32181373
2. Aqrawi LA, Chen X, Hynne H, Amdal C, Reppe S, Aass HCD, Rykke M, Hove LH, Young A, Herlofson BB, Westgaard KL, Utheim TP, Galtung HK, Jensen JL (2020)
   Cytokines Explored in Saliva and Tears from Radiated Cancer Patients Correlate with Clinical Manifestations, Influencing Important Immunoregulatory Cellular Pathways
   Cells, 9 (9)
   DOI 10.3390/cells9092050, PubMed 32911805
3. Astrup GL, Hofsø K, Bjordal K, Rustøen T (2020)
   Cancer patients' diagnosis and symptoms and their family caregivers' self-efficacy and social support are associated with different caregiver reactions
   Eur J Cancer Care (Engl), 29 (6), e13311
   DOI 10.1111/ecc.13311, PubMed 32885524
4. Bjelic-Radisic V, Cardoso F, Cameron D, Brain E, Kuljanic K, da Costa RA, Conroy T, Inwald EC, Serpentini S, Pinto M, Weis J, Morag O, Lindviksmoen Astrup G, Tomaszewski KA, Pogoda K, Sinai P, Sprangers M, Aaronson N, Velikova G, Greimel E, Arraras J, Bottomley A, EORTC Quality of Life Group and Breast Cancer Group (2020)
   Corrigendum to An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45: Ann Oncol 2020; Volume 31, Issue 2, Pages 283-288
   Ann Oncol, 31 (4), 552
   DOI 10.1016/j.annonc.2020.02.001, PubMed 32089397
5. Brandal P, Bergfeldt K, Aggerholm-Pedersen N, Bäckström G, Kerna I, Gubanski M, Björnlinger K, Evensen ME, Kuddu M, Pettersson E, Brydøy M, Hellebust TP, Dale E, Valdman A, Weber L, Høyer M (2020)
   A Nordic-Baltic perspective on indications for proton therapy with strategies for identification of proper patients
   Acta Oncol, 59 (10), 1157-1163
   DOI 10.1080/0284186X.2020.1817977, PubMed 32902341
6. Clarke M, Mackay A, Ismer B, Pickles JC, Tatevossian RG, Newman S, Bale TA, Stoler I, Izquierdo E, Temelso S, Carvalho DM, Molinari V, Burford A, Howell L, Virasami A, Fairchild AR, Avery A, Chalker J, Kristiansen M, Haupfear K, Dalton JD, Orisme W, Wen J, Hubank M, Kurian KM et al. (2020)
   Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes
   Cancer Discov, 10 (7), 942-963
   DOI 10.1158/2159-8290.CD-19-1030, PubMed 32238360
7. Digernes I, Nilsen LB, Grøvik E, Bjørnerud A, Løvland G, Vik-Mo E, Meling TR, Saxhaug C, Helland Å, Jacobsen KD, Geier O, Emblem KE (2020)
   Noise dependency in vascular parameters from combined gradient-echo and spin-echo DSC MRI
   Phys Med Biol, 65 (22), 225020
   DOI 10.1088/1361-6560/abb71a, PubMed 33200748
8. Flem-Karlsen K, Nyakas M, Farstad IN, McFadden E, Wernhoff P, Jacobsen KD, Flørenes VA, Mælandsmo GM (2020)
   Soluble AXL as a marker of disease progression and survival in melanoma
   PLoS One, 15 (1), e0227187
   DOI 10.1371/journal.pone.0227187, PubMed 31917795
9. Frič R, Due-Tønnessen BJ, Lundar T, Egge A, Kronen Krossnes B, Due-Tønnessen P, Stensvold E, Brandal P (2020)
   Long-term outcome of posterior fossa medulloblastoma in patients surviving more than 20 years following primary treatment in childhood
   Sci Rep, 10 (1), 9371
   DOI 10.1038/s41598-020-66328-8, PubMed 32523021
10. Hauge T, Amdal CD, Falk RS, Johannessen HO, Johnson E (2020)
    Long-term outcome in patients operated with hybrid esophagectomy for esophageal cancer - a cohort study
    Acta Oncol, 59 (7), 859-865
    DOI 10.1080/0284186X.2020.1750694, PubMed 32324079
11. Jeanmougin M, Håvik AB, Cekaite L, Brandal P, Sveen A, Meling TR, Ågesen TH, Scheie D, Heim S, Lothe RA, Lind GE (2020)
    Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment
    Mol Oncol, 14 (5), 1016-1027
    DOI 10.1002/1878-0261.12668, PubMed 32171051
12. Kierulf-Vieira KS, Sandberg CJ, Waaler J, Lund K, Skaga E, Saberniak BM, Panagopoulos I, Brandal P, Krauss S, Langmoen IA, Vik-Mo EO (2020)
    A Small-Molecule Tankyrase Inhibitor Reduces Glioma Stem Cell Proliferation and Sphere Formation
    Cancers (Basel), 12 (6)
    DOI 10.3390/cancers12061630, PubMed 32575464
13. König M, Osnes T, Bruland Ø, Sundby Hall K, Bratland Å, Meling TR (2020)
    The Role of Adjuvant Treatment in Craniofacial Malignancy: A Critical Review
    Front Oncol, 10, 1402
    DOI 10.3389/fonc.2020.01402, PubMed 32850452
14. Larsson C, Groote I, Vardal J, Kleppestø M, Odland A, Brandal P, Due-Tønnessen P, Holme SS, Hope TR, Meling TR, Fosse E, Emblem KE, Bjørnerud A (2020)
    Prediction of survival and progression in glioblastoma patients using temporal perfusion changes during radiochemotherapy
    Magn Reson Imaging, 68, 106-112
    DOI 10.1016/j.mri.2020.01.012, PubMed 32004711
15. Lorntzsen B, Jacobsen AB, GrØholt KK, Sigstad E, Osnes T (2020)
    Survival and Surgical Complications in Anaplastic Thyroid Cancer Patients After Completed Multimodal Treatment
    Anticancer Res, 40 (12), 6979-6985
    DOI 10.21873/anticanres.14722, PubMed 33288592
16. Lundar T, Due-Tønnessen BJ, Frič R, Brandal P, Stensvold E, Due-Tønnessen P (2020)
    Outcomes in adulthood after neurosurgical treatment of brain tumors in the first 3 years of life: long-term follow-up of a single consecutive institutional series of 97 patients
    Childs Nerv Syst, 37 (2), 427-433
    DOI 10.1007/s00381-020-04859-1, PubMed 32814984
17. Nilsen LB, Digernes I, Grøvik E, Saxhaug C, Latysheva A, Geier O, Breivik B, Sætre DO, Jacobsen KD, Helland Å, Emblem KE (2020)
    Responses in the diffusivity and vascular function of the irradiated normal brain are seen up until 18 months following SRS of brain metastases
    Neurooncol Adv, 2 (1), vdaa028
    DOI 10.1093/noajnl/vdaa028, PubMed 32642687
18. Rahman MA, Brekke J, Arnesen V, Hannisdal MH, Navarro AG, Waha A, Herfindal L, Rygh CB, Bratland E, Brandal P, Haasz J, Oltedal L, Miletic H, Lundervold A, Lie SA, Goplen D, Chekenya M (2020)
    Sequential bortezomib and temozolomide treatment promotes immunological responses in glioblastoma patients with positive clinical outcomes: A phase 1B study
    Immun Inflamm Dis, 8 (3), 342-359
    DOI 10.1002/iid3.315, PubMed 32578964
19. Stadskleiv K, Stensvold E, Stokka K, Bechensteen AG, Brandal P (2020)
    Neuropsychological functioning in survivors of childhood medulloblastoma/CNS-PNET: The role of secondary medical complications
    Clin Neuropsychol, 36 (3), 600-625
    DOI 10.1080/13854046.2020.1794045, PubMed 32729777
20. Stensvold E, Stadskleiv K, Myklebust TÅ, Wesenberg F, Helseth E, Bechensteen AG, Brandal P (2020)
    Unmet rehabilitation needs in 86% of Norwegian paediatric embryonal brain tumour survivors
    Acta Paediatr, 109 (9), 1875-1886
    DOI 10.1111/apa.15188, PubMed 31977119
21. von Döbeln GA, Wagenius G, Holtved E, Jacobsen AB, Nilsson M, Yu J, Baeksgaard L (2020)
    Definitive chemoradiotherapy plus cetuximab for cancer in the oesophagus or gastro-oesophageal junction
    Cancer Treat Res Commun, 24, 100187
    DOI 10.1016/j.ctarc.2020.100187, PubMed 32619832
22. Witt Nyström P, Bratland Å, Minn H, Grau C (2020)
    Ongoing and future clinical trials in particle therapy in the Nordic countries
    Acta Oncol, 59 (10), 1145-1150
    DOI 10.1080/0284186X.2020.1792548, PubMed 32673134

Publications 2019

1. Abravan A, Eide HA, Løndalen AM, Helland Å, Malinen E (2019)
   Mapping Bone Marrow Response in the Vertebral Column by Positron Emission Tomography Following Radiotherapy and Erlotinib Therapy of Lung Cancer
   Mol Imaging Biol, 21 (2), 391-398
   DOI 10.1007/s11307-018-1226-7, PubMed 29916117
2. Bjelic-Radisic V, Cardoso F, Cameron D, Brain E, Kuljanic K, da Costa RA, Conroy T, Inwald EC, Serpentini S, Pinto M, Weis J, Morag O, Lindviksmoen Astrup G, Tomaszweksi KA, Pogoda K, Sinai P, Sprangers M, Aaronson N, Velikova G, Greimel E, Arraras J, Bottomley A, EORTC Quality of Life Group and Breast Cancer Group (2019)
   An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45
   Ann Oncol, 31 (2), 283-288
   DOI 10.1016/j.annonc.2019.10.027, PubMed 31959345
3. Bogsrud TV, Londalen A, Brandal P, Leske H, Panagopoulos I, Borghammer P, Bach-Gansmo T (2019)
   18F-Fluciclovine PET/CT in Suspected Residual or Recurrent High-Grade Glioma
   Clin Nucl Med, 44 (8), 605-611
   DOI 10.1097/RLU.0000000000002641, PubMed 31274605
4. Brandstorp-Boesen J, Zätterström U, Evensen JF, Boysen M (2019)
   Value of patient-reported symptoms in the follow up of patients potentially cured of laryngeal carcinoma
   J Laryngol Otol, 133 (6), 508-514
   DOI 10.1017/S0022215119000677, PubMed 31006407
5. Burtness B, Harrington KJ, Greil R, Soulières D, Tahara M, de Castro G, Psyrri A, Basté N, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesía R, Ngamphaiboon N, Rordorf T, Wan Ishak WZ, Hong RL, González Mendoza R, Roy A, Zhang Y, Gumuscu B, Cheng JD, Jin F, Rischin D, KEYNOTE-048 Investigators (2019)
   Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
   Lancet, 394 (10212), 1915-1928
   DOI 10.1016/S0140-6736(19)32591-7, PubMed 31679945
6. Evensen JF, Sand Hansen H, Overgaard M, Johansen J, Andersen LJ, Overgaard J (2019)
   DAHANCA 9 - a randomized multicenter study to compare accelerated normo-fractionated radiotherapy with accelerated hyperfractionated radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC)
   Acta Oncol, 58 (10), 1502-1505
   DOI 10.1080/0284186X.2019.1629012, PubMed 31282236
7. Hong AM, Fogarty GB, Dolven-Jacobsen K, Burmeister BH, Lo SN, Haydu LE, Vardy JL, Nowak AK, Dhillon HM, Ahmed T, Shivalingam B, Long GV, Menzies AM, Hruby G, Drummond KJ, Mandel C, Middleton MR, Reisse CH, Paton EJ, Steel V, Williams NC, Scolyer RA, Morton RL, Thompson JF (2019)
   Adjuvant Whole-Brain Radiation Therapy Compared With Observation After Local Treatment of Melanoma Brain Metastases: A Multicenter, Randomized Phase III Trial
   J Clin Oncol, 37 (33), 3132-3141
   DOI 10.1200/JCO.19.01414, PubMed 31553661
8. König M, Osnes T, Bratland Å, Jebsen P, Meling TR (2019)
   Treatment of Sinonasal Adenocarcinoma: A Population-Based Prospective Cohort Study
   J Neurol Surg B Skull Base, 81 (6), 627-637
   DOI 10.1055/s-0039-1694050, PubMed 33381366
9. König M, Osnes T, Bratland Å, Meling TR (2019)
   Squamous Cell Carcinoma of the Paranasal Sinuses: A Single Center Experience
   J Neurol Surg B Skull Base, 81 (6), 664-672
   DOI 10.1055/s-0039-1694967, PubMed 33381371
10. Latysheva A, Emblem KE, Brandal P, Vik-Mo EO, Pahnke J, Røysland K, Hald JK, Server A (2019)
    Dynamic susceptibility contrast and diffusion MR imaging identify oligodendroglioma as defined by the 2016 WHO classification for brain tumors: histogram analysis approach
    Neuroradiology, 61 (5), 545-555
    DOI 10.1007/s00234-019-02173-5, PubMed 30712139
11. Lundar T, Due-Tønnessen BJ, Frič R, Brandal P, Stensvold E, Due-Tønnessen P (2019)
    Adult outcome after neurosurgical treatment of brain tumours in the first year of life: long-term follow-up of a single consecutive institutional series of 34 patients
    Acta Neurochir (Wien), 161 (9), 1793-1798
    DOI 10.1007/s00701-019-04014-z, PubMed 31309304
12. Moan JM, Amdal CD, Malinen E, Svestad JG, Bogsrud TV, Dale E (2019)
    The prognostic role of 18F-fluorodeoxyglucose PET in head and neck cancer depends on HPV status
    Radiother Oncol, 140, 54-61
    DOI 10.1016/j.radonc.2019.05.019, PubMed 31177043
13. Nyakas M, Aamdal E, Jacobsen KD, Guren TK, Aamdal S, Hagene KT, Brunsvig P, Yndestad A, Halvorsen B, Tasken KA, Aukrust P, Maelandsmo GM, Ueland T (2019)
    Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma
    Clin Exp Immunol, 197 (1), 74-82
    DOI 10.1111/cei.13283, PubMed 30821848
14. Richartz N, Duthil E, Ford A, Naderi EH, Bhagwat S, Gilljam KM, Burman MM, Ruud E, Blomhoff HK, Skah S (2019)
    Targeting cyclooxygenase by indomethacin decelerates progression of acute lymphoblastic leukemia in a xenograft model
    Blood Adv, 3 (21), 3181-3190
    DOI 10.1182/bloodadvances.2019000473, PubMed 31698450
15. Röhrl K, Guren MG, Astrup GL, Småstuen MC, Rustøen T (2019)
    High symptom burden is associated with impaired quality of life in colorectal cancer patients during chemotherapy:A prospective longitudinal study
    Eur J Oncol Nurs, 44, 101679
    DOI 10.1016/j.ejon.2019.101679, PubMed 31751848
16. Singer S, Amdal CD, Hammerlid E, Tomaszewska IM, Castro Silva J, Mehanna H, Santos M, Inhestern J, Brannan C, Yarom N, Fullerton A, Pinto M, Arraras JI, Kiyota N, Bonomo P, Sherman AC, Baumann I, Galalae R, Fernandez Gonzalez L, Nicolatou-Galitis O, Abdel-Hafeez Z, Raber-Durlacher J, Schmalz C, Zotti P, Boehm A et al. (2019)
    International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IV
    Head Neck, 41 (6), 1725-1737
    DOI 10.1002/hed.25609, PubMed 30636188
17. Stensvold E, Myklebust TÅ, Cappelen J, Due-Tønnessen BJ, Due-Tønnessen P, Kepka A, Johannesen TB, Krossnes B, Lundar T, Maric S, Miletic H, Moholdt V, Myrmel KS, Nordberg T, Rydland J, Stokland T, Solem K, Solheim O, Torsvik I, Wikran GC, Zeller B, Wesenberg F, Bechensteen AG, Brandal P (2019)
    Children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor in Norway from 1974 through 2013: Unexplainable regional differences in survival
    Pediatr Blood Cancer, 66 (10), e27910
    DOI 10.1002/pbc.27910, PubMed 31264356
18. Stokkevåg CH, Indelicato DJ, Herfarth K, Magelssen H, Evensen ME, Ugland M, Nordberg T, Nystad TA, Hægeland C, Alsaker MD, Ulven K, Dale JE, Engeseth GM, Boer CG, Toussaint L, Kornerup JS, Pettersen HES, Brydøy M, Brandal P, Muren LP (2019)
    Normal tissue complication probability models in plan evaluation of children with brain tumors referred to proton therapy
    Acta Oncol, 58 (10), 1416-1422
    DOI 10.1080/0284186X.2019.1643496, PubMed 31364899
19. Sunde B, Johnsen G, Jacobsen AB, Glenjen NI, Friesland S, Lindblad M, Rouvelas I, Wang N, Lundell L, Lagergren P, Nilsson M (2019)
    Effects of neoadjuvant chemoradiotherapy vs chemotherapy alone on the relief of dysphagia in esophageal cancer patients: secondary endpoint analysis in a randomized trial
    Dis Esophagus, 32 (2)
    DOI 10.1093/dote/doy069, PubMed 30084992
20. Sunde B, Klevebro F, Johar A, Johnsen G, Jacobsen AB, Glenjen NI, Friesland S, Lindblad M, Ajengui A, Lundell L, Lagergren P, Nilsson M (2019)
    Health-related quality of life in a randomized trial of neoadjuvant chemotherapy or chemoradiotherapy plus surgery in patients with oesophageal cancer (NeoRes trial)
    Br J Surg, 106 (11), 1452-1463
    DOI 10.1002/bjs.11246, PubMed 31436322
21. von Döbeln GA, Klevebro F, Jacobsen AB, Johannessen HO, Nielsen NH, Johnsen G, Hatlevoll I, Glenjen NI, Friesland S, Lundell L, Yu J, Nilsson M (2019)
    Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or gastroesophageal junction: long-term results of a randomized clinical trial
    Dis Esophagus, 32 (2)
    DOI 10.1093/dote/doy078, PubMed 30137281

Publications 2018

1. Brøndum L, Alsner J, Sørensen BS, Maare C, Johansen J, Primdahl H, Evensen JF, Kristensen CA, Andersen LJ, Overgaard J, Eriksen JG (2018)
   Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab: results from the DAHANCA 19 trial
   Acta Oncol, 57 (9), 1159-1164
   DOI 10.1080/0284186X.2018.1464664, PubMed 29771169
2. Dale E, Waldeland E (2018)
   Proton therapy - a reality in Norway from 2023
   Tidsskr Nor Laegeforen, 138 (13)
   DOI 10.4045/tidsskr.18.0250, PubMed 30180494
3. Digernes I, Grøvik E, Nilsen LB, Saxhaug C, Geier O, Reitan E, Sætre DO, Breivik B, Reese T, Jacobsen KD, Helland Å, Emblem KE (2018)
   Brain metastases with poor vascular function are susceptible to pseudoprogression after stereotactic radiation surgery
   Adv Radiat Oncol, 3 (4), 559-567
   DOI 10.1016/j.adro.2018.05.005, PubMed 30370356
4. Eide HA, Knudtsen IS, Sandhu V, Løndalen AM, Halvorsen AR, Abravan A, Kure EH, Bogsrud TV, Brustugun OT, Kyte JA, Malinen E, Helland Å (2018)
   Serum cytokine profiles and metabolic tumor burden in patients with non-small cell lung cancer undergoing palliative thoracic radiation therapy
   Adv Radiat Oncol, 3 (2), 130-138
   DOI 10.1016/j.adro.2017.12.007, PubMed 29904737
5. Enden T, Bernklev T, Jelsness-Jorgensen LP, Amdal CD (2018)
   Patients know their own health best
   Tidsskr. Nor. Laegeforen., 138 (8), 716-718
6. Johannessen LE, Brandal P, Myklebust TÅ, Heim S, Micci F, Panagopoulos I (2018)
   MGMT Gene Promoter Methylation Status - Assessment of Two Pyrosequencing Kits and Three Methylation-specific PCR Methods for their Predictive Capacity in Glioblastomas
   Cancer Genomics Proteomics, 15 (6), 437-446
   DOI 10.21873/cgp.20102, PubMed 30343277
7. Lundar T, Due-Tønnessen BJ, Fric R, Egge A, Krossnes B, Due-Tønnessen P, Stensvold E, Brandal P (2018)
   Neurosurgical treatment of gangliogliomas in children and adolescents: long-term follow-up of a single-institution series of 32 patients
   Acta Neurochir (Wien), 160 (6), 1207-1214
   DOI 10.1007/s00701-018-3550-8, PubMed 29680921
8. Overgaard J, Hoff CM, Hansen HS, Specht L, Overgaard M, Lassen P, Andersen E, Johansen J, Andersen LJ, Evensen JF, Alsner J, Grau C (2018)
   DAHANCA 10 - Effect of darbepoetin alfa and radiotherapy in the treatment of squamous cell carcinoma of the head and neck. A multicenter, open-label, randomized, phase 3 trial by the Danish head and neck cancer group
   Radiother Oncol, 127 (1), 12-19
   DOI 10.1016/j.radonc.2018.02.018, PubMed 29523409
9. Panagopoulos I, Gorunova L, Leske H, Niehusmann P, Johannessen LE, Staurseth J, Øino N, Meling TR, Heim S, Micci F, Brandal P (2018)
   Pyrosequencing Analysis of MGMT Promoter Methylation in Meningioma
   Cancer Genomics Proteomics, 15 (5), 379-385
   DOI 10.21873/cgp.20096, PubMed 30194078
10. Skah S, Richartz N, Duthil E, Gilljam KM, Bindesbøll C, Naderi EH, Eriksen AB, Ruud E, Dirdal MM, Simonsen A, Blomhoff HK (2018)
    cAMP-mediated autophagy inhibits DNA damage-induced death of leukemia cells independent of p53
    Oncotarget, 9 (54), 30434-30449
    DOI 10.18632/oncotarget.25758, PubMed 30100998
11. Skjøtskift T, Evensen ME, Furre T, Moan JM, Amdal CD, Bogsrud TV, Malinen E, Dale E (2018)
    Dose painting for re-irradiation of head and neck cancer
    Acta Oncol, 57 (12), 1693-1699
    DOI 10.1080/0284186X.2018.1512753, PubMed 30280623
12. Veierød MB, Page CM, Aaserud S, Bassarova A, Jacobsen KD, Helsing P, Robsahm TE (2018)
    Melanoma staging: Varying precision and terminal digit clustering in Breslow thickness data is evident in a population-based study
    J Am Acad Dermatol, 79 (1), 118-125.e1
    DOI 10.1016/j.jaad.2018.03.023, PubMed 29580861
13. Vistad I, Cvancarova M, Lindviksmoen Astrup G, Rustøen T, Liavaag AH (2018)
    Symptom Experience and Self-rated Physical Functioning in Patients With Ovarian Cancer Receiving Chemotherapy: A Longitudinal Study
    Int J Gynecol Cancer, 28 (6), 1167-1175
    DOI 10.1097/IGC.0000000000001287, PubMed 29781824

Publications 2017

1. Abravan A, Eide HA, Knudtsen IS, Løndalen AM, Helland Å, Malinen E (2017)
   Assessment of pulmonary ¹⁸F-FDG-PET uptake and cytokine profiles in non-small cell lung cancer patients treated with radiotherapy and erlotinib
   Clin Transl Radiat Oncol, 4, 57-63
   DOI 10.1016/j.ctro.2017.04.002, PubMed 29594209
2. Abravan A, Knudtsen IS, Eide HA, Løndalen AM, Helland Å, van Luijk P, Malinen E (2017)
   A new method to assess pulmonary changes using ¹⁸F-fluoro-2-deoxyglucose positron emission tomography for lung cancer patients following radiotherapy
   Acta Oncol, 56 (11), 1597-1603
   DOI 10.1080/0284186X.2017.1349336, PubMed 28849707
3. Amdal CD, Jacobsen AB, Falk RS, Johnson E, Os SS, Warloe T, Bjordal K (2017)
   Improved treatment decisions in patients with esophageal cancer
   Acta Oncol, 56 (10), 1286-1294
   DOI 10.1080/0284186X.2017.1346379, PubMed 28686501
4. Astrup GL, Hofsø K, Bjordal K, Guren MG, Vistad I, Cooper B, Miaskowski C, Rustøen T (2017)
   Patient factors and quality of life outcomes differ among four subgroups of oncology patients based on symptom occurrence
   Acta Oncol, 56 (3), 462-470
   DOI 10.1080/0284186X.2016.1273546, PubMed 28077018
5. Astrup GL, Rustøen T, Hofsø K, Gran JM, Bjordal K (2017)
   Symptom burden and patient characteristics: Association with quality of life in patients with head and neck cancer undergoing radiotherapy
   Head Neck, 39 (10), 2114-2126
   DOI 10.1002/hed.24875, PubMed 28766791
6. Jacobsen AB, Grøholt KK, Lorntzsen B, Osnes TA, Falk RS, Sigstad E (2017)
   Anaplastic thyroid cancer and hyperfractionated accelerated radiotherapy (HART) with and without surgery
   Eur Arch Otorhinolaryngol, 274 (12), 4203-4209
   DOI 10.1007/s00405-017-4764-8, PubMed 29019001
7. Johansen S, Norman MH, Dale E, Amdal CD, Furre T, Malinen E, Evensen JF (2017)
   Patterns of local-regional recurrence after conformal and intensity-modulated radiotherapy for head and neck cancer
   Radiat Oncol, 12 (1), 87
   DOI 10.1186/s13014-017-0829-5, PubMed 28545588
8. König M, Osnes T, Jebsen P, Evensen JF, Meling TR (2017)
   Olfactory neuroblastoma: a single-center experience
   Neurosurg Rev, 41 (1), 323-331
   DOI 10.1007/s10143-017-0859-3, PubMed 28540633
9. Leske H, Brandal P, Rushing EJ, Niehusmann P (2017)
   IDH-mutant giant cell glioblastoma: A neglected tumor variant?
   Clin Neuropathol, 36 (6), 293-295
   DOI 10.5414/NP301054, PubMed 29035191
10. Mikalsen LTG, Arnesen MR, Bogsrud TV, Dale E, Stokke C (2017)
    Combining radioiodine and external beam radiation therapy: the potential of integrated treatment planning for differentiated thyroid cancer
    Acta Oncol, 56 (6), 894-897
    DOI 10.1080/0284186X.2017.1286384, PubMed 28464741
11. Mäkitie AA, Cange HH, Hammarstedt-Nordenvall L, Gudjonsson A, Jóhannsson J, Laranne J, Mäenpää H, Rikardsen O, Bratland Å, Wessel I, Johansen J, Grau C (2017)
    Head and neck cancer management in the Nordic countries: an effort to harmonize treatment
    Eur Arch Otorhinolaryngol, 274 (5), 2363-2365
    DOI 10.1007/s00405-017-4456-4, PubMed 28124110
12. Stensvold E, Krossnes BK, Lundar T, Due-Tønnessen BJ, Frič R, Due-Tønnessen P, Bechensteen AG, Myklebust TÅ, Johannesen TB, Brandal P (2017)
    Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) - a retrospective analysis spanning 40 years of treatment
    Acta Oncol, 56 (5), 698-705
    DOI 10.1080/0284186X.2017.1301679, PubMed 28325133

Publications 2016

1. Boysen ME, Zätterström UK, Evensen JF (2016)
   Self-reported Symptoms to Monitor Recurrent Head and Neck Cancer-Analysis of 1,678 Cases
   Anticancer Res, 36 (6), 2849-54
   PubMed 27272796
2. Dale E, Moan JM, Osnes TA, Bogsrud TV (2016)
   Cervical lymph node metastases of squamous cell carcinoma of unknown origin: the diagnostic value of FDG PET/CT and clinical outcome
   Eur Arch Otorhinolaryngol, 274 (2), 1015-1019
   DOI 10.1007/s00405-016-4318-5, PubMed 27671150
3. Eide HA, Halvorsen AR, Bjaanæs MM, Piri H, Holm R, Solberg S, Jørgensen L, Brustugun OT, Kiserud CE, Helland Å (2016)
   The MYCN-HMGA2-CDKN2A pathway in non-small cell lung carcinoma--differences in histological subtypes
   BMC Cancer, 16, 71
   DOI 10.1186/s12885-016-2104-9, PubMed 26858029
4. Gulati G, Heck SL, Ree AH, Hoffmann P, Schulz-Menger J, Fagerland MW, Gravdehaug B, von Knobelsdorff-Brenkenhoff F, Bratland Å, Storås TH, Hagve TA, Røsjø H, Steine K, Geisler J, Omland T (2016)
   Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol
   Eur Heart J, 37 (21), 1671-80
   DOI 10.1093/eurheartj/ehw022, PubMed 26903532
5. Hjermstad MJ, Bergenmar M, Bjordal K, Fisher SE, Hofmeister D, Montel S, Nicolatou-Galitis O, Pinto M, Raber-Durlacher J, Singer S, Tomaszewska IM, Tomaszewski KA, Verdonck-de Leeuw I, Yarom N, Winstanley JB, Herlofson BB, EORTC QoL Group (2016)
   International field testing of the psychometric properties of an EORTC quality of life module for oral health: the EORTC QLQ-OH15
   Support Care Cancer, 24 (9), 3915-24
   DOI 10.1007/s00520-016-3216-0, PubMed 27113466
6. Klevebro F, Alexandersson von Döbeln G, Wang N, Johnsen G, Jacobsen AB, Friesland S, Hatlevoll I, Glenjen NI, Lind P, Tsai JA, Lundell L, Nilsson M (2016)
   A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction
   Ann Oncol, 27 (4), 660-7
   DOI 10.1093/annonc/mdw010, PubMed 26782957
7. Olsen TK, Panagopoulos I, Gorunova L, Micci F, Andersen K, Kilen Andersen H, Meling TR, Due-Tønnessen B, Scheie D, Heim S, Brandal P (2016)
   Novel fusion genes and chimeric transcripts in ependymal tumors
   Genes Chromosomes Cancer, 55 (12), 944-953
   DOI 10.1002/gcc.22392, PubMed 27401149
8. Vandraas K, Tjønnfjord GE, Johannesen TB, Brandal P (2016)
   Persistent bone marrow depression following short-term treatment with temozolomide
   BMJ Case Rep, 2016
   DOI 10.1136/bcr-2016-215797, PubMed 27130558
9. Varghese M, Nymoen HG, Saxhaug C, Krossnes B, Abdol Mohieb Hosainey S, Meling TR, Brandal P (2016)
   Symptomatic spinal metastasis from intracranial glioblastoma multiforme - Two illustrative cases and a review of the literature
   Acta Oncol, 55 (9-10), 1236-1238
   DOI 10.3109/0284186X.2016.1161824, PubMed 27174685

Publications 2015

1. Arnesen MR, Knudtsen IS, Rekstad BL, Eilertsen K, Dale E, Bruheim K, Helland Å, Løndalen AM, Hellebust TP, Malinen E (2015)
   Dose painting by numbers in a standard treatment planning system using inverted dose prescription maps
   Acta Oncol, 54 (9), 1607-13
   DOI 10.3109/0284186X.2015.1061690, PubMed 26213311
2. Astrup GL, Rustøen T, Miaskowski C, Paul SM, Bjordal K (2015)
   A Longitudinal Study of Depressive Symptoms in Patients With Head and Neck Cancer Undergoing Radiotherapy
   Cancer Nurs, 38 (6), 436-46
   DOI 10.1097/NCC.0000000000000225, PubMed 25643005
3. Astrup GL, Rustøen T, Miaskowski C, Paul SM, Bjordal K (2015)
   Changes in and predictors of pain characteristics in patients with head and neck cancer undergoing radiotherapy
   Pain, 156 (5), 967-979
   DOI 10.1097/j.pain.0000000000000142, PubMed 25719616
4. Cehajic I, Bergan S, Bjordal K (2015)
   Pharmacist assessment of drug-related problems on an oncology ward
   Eur. J. Hosp. Pharm., 22 (4), 194-197
   DOI 10.1136/ejhpharm-2014-000510
5. Due-Tønnessen BJ, Egge A, Lundar T, Krossnes B, Stensvold E, Due-Tønnessen P, Brandal P (2015)
   Posterior fossa ependymoblastoma diagnosed in the second month of life: uneventful 12 years survival after gross total resection followed by chemotherapy
   Springerplus, 4, 389
   DOI 10.1186/s40064-015-1178-1, PubMed 26251773
6. Fogarty GB, Hong A, Dolven-Jacobsen K, Reisse CH, Burmeister B, Haydu LH, Dhillon H, Steel V, Shivalingam B, Drummond K, Vardy J, Nowak A, Hruby G, Scolyer RA, Mandel C, Thompson JF (2015)
   First interim analysis of a randomised trial of whole brain radiotherapy in melanoma brain metastases confirms high data quality
   BMC Res Notes, 8, 192
   DOI 10.1186/s13104-015-1153-5, PubMed 25952979
7. Klevebro F, Johnsen G, Johnson E, Viste A, Myrnäs T, Szabo E, Jacobsen AB, Friesland S, Tsai JA, Persson S, Lindblad M, Lundell L, Nilsson M (2015)
   Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: A randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation
   Eur J Surg Oncol, 41 (7), 920-6
   DOI 10.1016/j.ejso.2015.03.226, PubMed 25908010
8. Lundar T, Due-Tønnessen BJ, Egge A, Krossnes B, Stensvold E, Due-Tønnessen P, Brandal P (2015)
   Neurosurgical treatment of brain tumors in the first 6 months of life: long-term follow-up of a single consecutive institutional series of 30 patients
   Childs Nerv Syst, 31 (12), 2283-90
   DOI 10.1007/s00381-015-2792-5, PubMed 26174616
9. Olsen TK, Panagopoulos I, Meling TR, Micci F, Gorunova L, Thorsen J, Due-Tønnessen B, Scheie D, Lund-Iversen M, Krossnes B, Saxhaug C, Heim S, Brandal P (2015)
   Fusion genes with ALK as recurrent partner in ependymoma-like gliomas: a new brain tumor entity?
   Neuro Oncol, 17 (10), 1365-73
   DOI 10.1093/neuonc/nov039, PubMed 25795305

Publications 2014

1. Dahl S, Loge JH, Berge V, Dahl AA, Cvancarova M, Fosså SD (2014)
   Influence of radical prostatectomy for prostate cancer on work status and working life 3 years after surgery
   J Cancer Surviv, 9 (2), 172-9
   DOI 10.1007/s11764-014-0399-6, PubMed 25216609
2. Dale E (2014)
   [Re: Brachytherapy for malignant uveal melanoma]
   Tidsskr Nor Laegeforen, 134 (8), 814
   DOI 10.4045/tidsskr.14.0467, PubMed 24780973
3. Eikesdal HP, Løes S, Herlofson BB (2014)
   [Dental health when using bisphosphonates against breast cancer]
   Tidsskr Nor Laegeforen, 134 (15), 1451
   DOI 10.4045/tidsskr.14.0717, PubMed 25138400
4. Fogarty GB, Hong A, Jacobsen KD, Reisse CH, Shivalingam B, Burmeister B, Haydu LE, Paton E, Thompson JF (2014)
   Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible
   BMC Res Notes, 7, 412
   DOI 10.1186/1756-0500-7-412, PubMed 24981506
5. Hofsø K, Bjordal K, Diep LM, Rustøen T (2014)
   The relationships between demographic and clinical characteristics and quality of life during and after radiotherapy: in women with breast cancer
   Qual Life Res, 23 (10), 2769-77
   DOI 10.1007/s11136-014-0736-2, PubMed 24952109
6. Hong AM, Suo C, Valenzuela M, Haydu LE, Jacobsen KD, Reisse CH, Fogarty G (2014)
   Low incidence of melanoma brain metastasis in the hippocampus
   Radiother Oncol, 111 (1), 59-62
   DOI 10.1016/j.radonc.2014.01.012, PubMed 24560764
7. Lassen P, Primdahl H, Johansen J, Kristensen CA, Andersen E, Andersen LJ, Evensen JF, Eriksen JG, Overgaard J, Danish Head and Neck Cancer Group (DAHANCA) (2014)
   Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer
   Radiother Oncol, 113 (3), 310-6
   DOI 10.1016/j.radonc.2014.11.032, PubMed 25544647
8. Lundar T, Due-Tønnessen BJ, Egge A, Scheie D, Brandal P, Stensvold E, Due-Tønnessen P (2014)
   Neurosurgical treatment of pediatric low-grade midbrain tumors: a single consecutive institutional series of 15 patients
   J Neurosurg Pediatr, 14 (6), 598-603
   DOI 10.3171/2014.9.PEDS1462, PubMed 25325421
9. Lundar T, Due-Tønnessen BJ, Scheie D, Brandal P (2014)
   Pediatric spinal ependymomas: an unpredictable and puzzling disease. Long-term follow-up of a single consecutive institutional series of ten patients
   Childs Nerv Syst, 30 (12), 2083-8
   DOI 10.1007/s00381-014-2491-7, PubMed 25079883
10. von der Lippe C, Roscher I, Nordgarden H, Rustad C, Larsen SM, Mjøen E, Bratland Å (2014)
    Man with macrocephaly, learning disability and multiple basal cell carcinomas
    Tidsskr Nor Laegeforen, 134 (11), 1151-4
    DOI 10.4045/tidsskr.13.0894, PubMed 24939783
11. Zätterström U, Boysen M, Evensen JF (2014)
    Significance of self-reported symptoms as part of follow-up routines in patients treated for oral squamous cell carcinoma
    Anticancer Res, 34 (11), 6593-9
    PubMed 25368263

Publications 2013

1. Amdal CD, Jacobsen AB, Sandstad B, Warloe T, Bjordal K (2013)
   Palliative brachytherapy with or without primary stent placement in patients with oesophageal cancer, a randomised phase III trial
   Radiother Oncol, 107 (3), 428-33
   DOI 10.1016/j.radonc.2013.04.008, PubMed 23647761
2. Dahl S, Steinsvik EA, Dahl AA, Loge JH, Cvancarova M, Fosså SD (2013)
   Return to work and sick leave after radical prostatectomy: a prospective clinical study
   Acta Oncol, 53 (6), 744-51
   DOI 10.3109/0284186X.2013.844357, PubMed 24195691
3. Geisler J, Bachmann IM, Nyakas M, Helsing P, Fjøsne HE, Mæhle LO, Aamdal S, Eide NA, Svendsen HL, Straume O, Robsahm TE, Jacobsen KD, Akslen LA (2013)
   Malignant melanoma--diagnosis, treatment and follow-up in Norway
   Tidsskr Nor Laegeforen, 133 (20), 2154-9
   DOI 10.4045/tidsskr.12.1416, PubMed 24172628
4. Gulati G, Heck SL, Ree AH, Gravdehaug B, Røsjø H, Steine K, Bratland Å, Hoffmann P, Geisler J, Omland T (2013)
   [Cardioprotective treatment during adjuvant cancer therapy]
   Tidsskr Nor Laegeforen, 133 (17), 1832-6
   DOI 10.4045/tidsskr.12.1514, PubMed 24042297
5. Håvik AB, Lind GE, Honne H, Meling TR, Scheie D, Hall KS, van den Berg E, Mertens F, Picci P, Lothe RA, Heim S, Brandal P (2013)
   Sequencing IDH1/2 glioma mutation hotspots in gliomas and malignant peripheral nerve sheath tumors
   Neuro Oncol, 16 (2), 320-2
   DOI 10.1093/neuonc/not230, PubMed 24311631
6. Krüger TB, Sharikabad MN, Herlofson BB (2013)
   Bisphosphonate-related osteonecrosis of the jaw in four Nordic countries and an indication of under-reporting
   Acta Odontol Scand, 71 (6), 1386-90
   DOI 10.3109/00016357.2013.764007, PubMed 23351164
7. Lindviksmoen G, Hofsø K, Paul SM, Miaskowski C, Rustøen T (2013)
   Predictors of initial levels and trajectories of depressive symptoms in women with breast cancer undergoing radiation therapy
   Cancer Nurs, 36 (6), E34-43
   DOI 10.1097/NCC.0b013e31826fc9cc, PubMed 23132125
8. Lundar T, Due-Tønnessen BJ, Egge A, Scheie D, Stensvold E, Brandal P (2013)
   Neurosurgical treatment of oligodendroglial tumors in children and adolescents: a single-institution series of 35 consecutive patients
   J Neurosurg Pediatr, 12 (3), 241-6
   DOI 10.3171/2013.6.PEDS12586, PubMed 23870041
9. Mortensen HR, Overgaard J, Jensen K, Specht L, Overgaard M, Johansen J, Evensen JF, Andersen E, Andersen LJ, Hansen HS, Grau C, DAHANCA Group (2013)
   Factors associated with acute and late dysphagia in the DAHANCA 6 & 7 randomized trial with accelerated radiotherapy for head and neck cancer
   Acta Oncol, 52 (7), 1535-42
   DOI 10.3109/0284186X.2013.824609, PubMed 24047339
10. Quinten C, Martinelli F, Coens C, Sprangers MA, Ringash J, Gotay C, Bjordal K, Greimel E, Reeve BB, Maringwa J, Ediebah DE, Zikos E, King MT, Osoba D, Taphoorn MJ, Flechtner H, Schmucker-Von Koch J, Weis J, Bottomley A, Patient Reported Outcomes and Behavioral Evidence (PROBE) and the European Organization for Research and Treatment of Cancer (EORTC) Clinical Groups (2013)
    A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites
    Cancer, 120 (2), 302-11
    DOI 10.1002/cncr.28382, PubMed 24127333
11. Rogne SG, Helseth E, Brandal P, Scheie D, Meling TR (2013)
    Are melanomas averse to cerebellum? Cerebellar metastases in a surgical series
    Acta Neurol Scand, 130 (1), 1-10
    DOI 10.1111/ane.12206, PubMed 24313862
12. Røe K, Bratland Å, Vlatkovic L, Ragnum HB, Saelen MG, Olsen DR, Marignol L, Ree AH (2013)
    Hypoxic tumor kinase signaling mediated by STAT5A in development of castration-resistant prostate cancer
    PLoS One, 8 (5), e63723
    DOI 10.1371/journal.pone.0063723, PubMed 23675504

Publications 2012

1. Amdal CD, Jacobsen AB, Guren MG, Bjordal K (2012)
   Patient-reported outcomes evaluating palliative radiotherapy and chemotherapy in patients with oesophageal cancer: a systematic review
   Acta Oncol, 52 (4), 679-90
   DOI 10.3109/0284186X.2012.731521, PubMed 23190360
2. Andreassen TN, Klepstad P, Davies A, Bjordal K, Lundström S, Kaasa S, Dale O (2012)
   Is oxycodone efficacy reflected in serum concentrations? A multicenter, cross-sectional study in 456 adult cancer patients
   J Pain Symptom Manage, 43 (4), 694-705
   DOI 10.1016/j.jpainsymman.2011.05.008, PubMed 22285284
3. Heck SL, Gulati G, Ree AH, Schulz-Menger J, Gravdehaug B, Røsjø H, Steine K, Bratland A, Hoffmann P, Geisler J, Omland T (2012)
   Rationale and design of the prevention of cardiac dysfunction during an Adjuvant Breast Cancer Therapy (PRADA) Trial
   Cardiology, 123 (4), 240-7
   DOI 10.1159/000343622, PubMed 23207160
4. Hjermstad MJ, Bergenmar M, Fisher SE, Montel S, Nicolatou-Galitis O, Raber-Durlacher J, Singer S, Verdonck-de Leeuw I, Weis J, Yarom N, Herlofson BB (2012)
   The EORTC QLQ-OH17: a supplementary module to the EORTC QLQ-C30 for assessment of oral health and quality of life in cancer patients
   Eur J Cancer, 48 (14), 2203-11
   DOI 10.1016/j.ejca.2012.04.003, PubMed 22572480
5. Hofsø K, Miaskowski C, Bjordal K, Cooper BA, Rustøen T (2012)
   Previous chemotherapy influences the symptom experience and quality of life of women with breast cancer prior to radiation therapy
   Cancer Nurs, 35 (3), 167-77
   DOI 10.1097/NCC.0b013e31821f5eb5, PubMed 21760482
6. Hofsø K, Rustøen T, Cooper BA, Bjordal K, Miaskowski C (2012)
   Changes over time in occurrence, severity, and distress of common symptoms during and after radiation therapy for breast cancer
   J Pain Symptom Manage, 45 (6), 980-1006
   DOI 10.1016/j.jpainsymman.2012.06.003, PubMed 23026547
7. Håvik AB, Brandal P, Honne H, Dahlback HS, Scheie D, Hektoen M, Meling TR, Helseth E, Heim S, Lothe RA, Lind GE (2012)
   MGMT promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR
   J Transl Med, 10, 36
   DOI 10.1186/1479-5876-10-36, PubMed 22390413
8. Khullar SM, Tvedt D, Chapman K, Herlofson BB (2012)
   Sixty cases of extreme osteonecrosis and osteomyelitis of the mandible and maxilla in a West African population
   Int J Oral Maxillofac Surg, 41 (8), 978-85
   DOI 10.1016/j.ijom.2012.04.022, PubMed 22652445
9. Larsson C, Kleppestø M, Rasmussen I, Salo R, Vardal J, Brandal P, Bjørnerud A (2012)
   Sampling requirements in DCE-MRI based analysis of high grade gliomas: simulations and clinical results
   J Magn Reson Imaging, 37 (4), 818-29
   DOI 10.1002/jmri.23866, PubMed 23086710
10. Mortensen HR, Overgaard J, Specht L, Overgaard M, Johansen J, Evensen JF, Andersen LJ, Andersen E, Grau C (2012)
    Prevalence and peak incidence of acute and late normal tissue morbidity in the DAHANCA 6&7 randomised trial with accelerated radiotherapy for head and neck cancer
    Radiother Oncol, 103 (1), 69-75
    DOI 10.1016/j.radonc.2012.01.002, PubMed 22398313
11. Skretting A, Evensen JF, Løndalen AM, Bogsrud TV, Glomset OK, Eilertsen K (2012)
    A gel tumour phantom for assessment of the accuracy of manual and automatic delineation of gross tumour volume from FDG-PET/CT
    Acta Oncol, 52 (3), 636-44
    DOI 10.3109/0284186X.2012.718095, PubMed 23075421
12. Waldeland E, Brustugun OT, Ramberg C, Helland Å (2012)
    [Stereotactic irradiation in spinal metastases]
    Tidsskr Nor Laegeforen, 132 (22), 2478-9
    DOI 10.4045/tidsskr.12.1108, PubMed 23338027
13. Wilberg P, Hjermstad MJ, Ottesen S, Herlofson BB (2012)
    Oral health is an important issue in end-of-life cancer care
    Support Care Cancer, 20 (12), 3115-22
    DOI 10.1007/s00520-012-1441-8, PubMed 22434497

Publications 2011

1. Amdal CD, Jacobsen AB, Tausjø JE, Wiig JN, Warloe T, Sandstad B, Bjordal K (2011)
   Palliative interventions and prognosis in patients with advanced esophageal cancer
   Dis Esophagus, 24 (7), 502-9
   DOI 10.1111/j.1442-2050.2010.01174.x, PubMed 21309923
2. Andreassen TN, Eftedal I, Klepstad P, Davies A, Bjordal K, Lundström S, Kaasa S, Dale O (2011)
   Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study
   Eur J Clin Pharmacol, 68 (1), 55-64
   DOI 10.1007/s00228-011-1093-5, PubMed 21735164
3. Dahlback HS, Brandal P, Gorunova L, Widing E, Meling TR, Krossnes BK, Heim S (2011)
   Genomic aberrations in pediatric gliomas and embryonal tumors
   Genes Chromosomes Cancer, 50 (10), 788-99
   DOI 10.1002/gcc.20898, PubMed 21717527
4. Dahlback HS, Brandal P, Krossnes BK, Fric R, Meling TR, Meza-Zepeda LA, Danielsen HE, Heim S (2011)
   Multiple chromosomal monosomies are characteristic of giant cell ependymoma
   Hum Pathol, 42 (12), 2042-6
   DOI 10.1016/j.humpath.2011.02.012, PubMed 21683982
5. Dahlback HS, Gorunova L, Brandal P, Scheie D, Helseth E, Meling TR, Heim S (2011)
   Genomic aberrations in diffuse low-grade gliomas
   Genes Chromosomes Cancer, 50 (6), 409-20
   DOI 10.1002/gcc.20866, PubMed 21412929
6. Dahlback HS, Gorunova L, Micci F, Scheie D, Brandal P, Meling TR, Heim S (2011)
   Molecular cytogenetic analysis of a gliosarcoma with osseous metaplasia
   Cytogenet Genome Res, 134 (2), 88-95
   DOI 10.1159/000326804, PubMed 21555877
7. Fjösne HE, Søreide JA, Kåresen R, Lønning PE, Jacobsen AB, Lundgren S, NORWEGIAN BREAST CANCER GROUP (NBCG) (2011)
   Hospital volume and prognosis among Norwegian breast cancer patients enrolled in adjuvant trials
   Acta Oncol, 50 (7), 1068-74
   DOI 10.3109/0284186X.2011.585998, PubMed 21745131
8. Hoff CM, Lassen P, Eriksen JG, Hansen HS, Specht L, Overgaard M, Grau C, Johansen J, Bentzen J, Andersen L, Evensen JF, Overgaard J (2011)
   Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? - results from the randomized DAHANCA 5 and 7 trials
   Acta Oncol, 50 (7), 1006-14
   DOI 10.3109/0284186X.2011.592650, PubMed 21790306
9. Klepstad P, Fladvad T, Skorpen F, Bjordal K, Caraceni A, Dale O, Davies A, Kloke M, Lundström S, Maltoni M, Radbruch L, Sabatowski R, Sigurdardottir V, Strasser F, Fayers PM, Kaasa S, European Palliative Care Research Collaborative (EPCRC) and the European Association for Palliative Care Research Network (2011)
   Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients
   Pain, 152 (5), 1139-1145
   DOI 10.1016/j.pain.2011.01.040, PubMed 21398039
10. Kyriazoglou AI, Dimitriadis E, Arnogiannaki N, Brandal P, Heim S, Pandis N (2011)
    Similar cytogenetic findings in two synchronous secondary peripheral chondrosarcomas in a patient with multiple osteochondromas
    Cancer Genet, 204 (12), 677-81
    DOI 10.1016/j.cancergen.2011.10.013, PubMed 22285020

Publications 2010

1. Andreassen TN, Klepstad P, Davies A, Bjordal K, Lundström S, Kaasa S, Dale O (2010)
   Influences on the pharmacokinetics of oxycodone: a multicentre cross-sectional study in 439 adult cancer patients
   Eur J Clin Pharmacol, 67 (5), 493-506
   DOI 10.1007/s00228-010-0948-5, PubMed 21140139
2. Dale E, Hårsaker V, Kristoffersen DT, Bruland O, Olsen DR (2010)
   CT density in lung cancer patients after radiotherapy sensitized by metoclopramide. A subgroup analysis of a randomized trial
   Strahlenther Onkol, 186 (3), 163-8
   DOI 10.1007/s00066-010-2040-6, PubMed 20165821
3. Jacobsen KD, Tausjø J, Hager B, Gundersen S (2010)
   [Treatment of metastatic malignant melanoma localized to an extremity]
   Tidsskr Nor Laegeforen, 130 (1), 21-4
   DOI 10.4045/tidsskr.09.0701, PubMed 20094118
4. Utne I, Miaskowski C, Bjordal K, Paul SM, Rustoen T (2010)
   The relationships between mood disturbances and pain, hope, and quality of life in hospitalized cancer patients with pain on regularly scheduled opioid analgesic
   J Palliat Med, 13 (3), 311-8
   DOI 10.1089/jpm.2009.0294, PubMed 20078225
5. Wranicz P, Herlofson BB, Evensen JF, Kongsgaard UE (2010)
   Prevention and treatment of trismus in head and neck cancer: A case report and a systematic review of the literature
   Scand J Pain, 1 (2), 84-88
   DOI 10.1016/j.sjpain.2010.01.006, PubMed 29913945